Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02983604
Title GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer
Recruitment Terminated
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Gilead Sciences
Indications

Her2-receptor negative breast cancer

Therapies

Exemestane

Fulvestrant + GS-5829

Exemestane + GS-5829

Fulvestrant

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.